Zhejiang Orient Gene Biotech Co Ltd (688298) — Cash Flow Reinvestment Rate
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow Reinvestment Rate of 0.50x as of September 2022, reinvesting CN¥155.73 Million (capex CN¥119.58 Million plus investments CN¥36.14 Million) from operating cash flow of CN¥309.89 Million. See cash generation quality of Zhejiang Orient Gene Biotech Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Orient Gene Biotech Co Ltd Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. For the full cash flow conversion analysis, see Zhejiang Orient Gene Biotech Co Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)
Year-by-year capital reinvestment analysis for Zhejiang Orient Gene Biotech Co Ltd. See Zhejiang Orient Gene Biotech Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.71x | CN¥2.13 Billion | CN¥3.00 Billion | CN¥1.05 Billion | ▲ +402.2% |
| 2021 | 0.14x | CN¥736.03 Million | CN¥5.20 Billion | CN¥507.87 Million | ▼ -55.1% |
| 2020 | 0.31x | CN¥563.93 Million | CN¥1.79 Billion | CN¥126.93 Million | ▼ -96.2% |
| 2019 | 8.28x | CN¥448.90 Million | CN¥54.21 Million | CN¥11.90 Million | ▼ -19.5% |
| 2018 | 10.28x | CN¥455.88 Million | CN¥44.33 Million | CN¥18.88 Million | ▼ -23.4% |
| 2017 | 13.43x | CN¥450.38 Million | CN¥33.54 Million | CN¥13.38 Million | ▲ +76.0% |
| 2016 | 7.63x | CN¥90.11 Million | CN¥11.81 Million | CN¥4.65 Million | — |